AAPL329.70-8.71 (-2.57%) ▼|ABBV263.82-2.46 (-0.92%) ▼|ABT100.84-0.15 (-0.14%) ▼|ACN177.06+2.59 (+1.48%) ▲|ADBE232.74+1.73 (+0.75%) ▲|AMAT511.28+24.52 (+5.04%) ▲|AMD607.39-0.49 (-0.08%) ▼|AMGN423.06+4.93 (+1.18%) ▲|AMT167.39-0.62 (-0.37%) ▼|AMZN246.80+0.65 (+0.26%) ▲|AVGO355.02+5.45 (+1.56%) ▲|AXP305.34-0.99 (-0.32%) ▼|BA187.60+3.21 (+1.74%) ▲|BAC55.03-0.45 (-0.80%) ▼|BKNG161.93-1.94 (-1.18%) ▼|BLK1,069.30-1.95 (-0.18%) ▼|BMY62.53-1.35 (-2.11%) ▼|BNY146.99-1.45 (-0.98%) ▼|BRK-B502.71-0.38 (-0.08%) ▼|C130.96-0.35 (-0.27%) ▼|CAT827.55+7.60 (+0.93%) ▲|CL86.39-0.14 (-0.16%) ▼|CMCSA21.57-0.22 (-1.02%) ▼|COF196.88+0.42 (+0.21%) ▲|COP125.45-0.59 (-0.47%) ▼|COST924.62+1.70 (+0.18%) ▲|CRM225.73-1.54 (-0.68%) ▼|CSCO106.94+0.20 (+0.18%) ▲|CVS86.66-1.19 (-1.35%) ▼|CVX204.13-2.24 (-1.09%) ▼|DE680.05-9.54 (-1.38%) ▼|DHR226.01-1.32 (-0.58%) ▼|DIS105.14-0.46 (-0.43%) ▼|DUK114.32+0.91 (+0.80%) ▲|EMR157.40-1.99 (-1.25%) ▼|FDX287.41-2.25 (-0.78%) ▼|GD332.33-1.83 (-0.55%) ▼|GE318.84+0.60 (+0.19%) ▲|GEV964.19+14.42 (+1.52%) ▲|GILD151.38-0.84 (-0.55%) ▼|GM80.23-0.42 (-0.51%) ▼|GOOG338.26-0.90 (-0.27%) ▼|GOOGL341.74-1.01 (-0.29%) ▼|GS915.75-0.53 (-0.06%) ▼|HD288.33-1.56 (-0.54%) ▼|HON210.55-0.97 (-0.46%) ▼|IBM220.25-0.42 (-0.19%) ▼|INTC115.89-0.14 (-0.12%) ▼|INTU266.82-2.58 (-0.96%) ▼|ISRG412.62-2.17 (-0.52%) ▼|JNJ267.57-4.38 (-1.61%) ▼|JPM335.13-1.46 (-0.43%) ▼|KO86.92-0.26 (-0.30%) ▼|LIN474.45+2.41 (+0.51%) ▲|LLY1,183.98-0.80 (-0.07%) ▼|LMT512.72-5.39 (-1.04%) ▼|LOW187.17-0.50 (-0.26%) ▼|LRCX323.55+9.08 (+2.89%) ▲|MA564.61-3.65 (-0.64%) ▼|MCD233.79+0.19 (+0.08%) ▲|MDLZ59.41-0.77 (-1.28%) ▼|MDT87.21-2.30 (-2.56%) ▼|META736.84+21.22 (+2.97%) ▲|MMM168.68-0.80 (-0.47%) ▼|MO68.62-0.51 (-0.74%) ▼|MRK149.07+0.38 (+0.26%) ▲|MS192.82-0.82 (-0.42%) ▼|MSFT509.81+0.59 (+0.12%) ▲|MU1,068.20+14.22 (+1.35%) ▲|NEE76.00+0.51 (+0.67%) ▲|NFLX70.31+1.08 (+1.56%) ▲|NKE35.88-0.51 (-1.40%) ▼|NOW130.00-1.45 (-1.10%) ▼|NVDA227.97-0.89 (-0.39%) ▼|ORCL138.33+5.73 (+4.32%) ▲|PEP128.77+0.27 (+0.21%) ▲|PFE28.62-0.10 (-0.33%) ▼|PG148.27-0.76 (-0.51%) ▼|PLTR186.79-0.70 (-0.37%) ▼|PM193.43-0.33 (-0.17%) ▼|QCOM183.95-3.53 (-1.88%) ▼|RTX187.19-0.47 (-0.25%) ▼|SBUX95.43+0.16 (+0.17%) ▲|SCHW99.10+0.80 (+0.81%) ▲|SO83.47+1.12 (+1.35%) ▲|SPG204.31-0.22 (-0.11%) ▼|T24.49-0.41 (-1.65%) ▼|TMO680.15+1.55 (+0.23%) ▲|TMUS163.19-3.27 (-1.96%) ▼|TSLA352.76-4.69 (-1.31%) ▼|TXN281.69+3.38 (+1.21%) ▲|UBER69.39+1.23 (+1.80%) ▲|UNH374.95-2.88 (-0.76%) ▼|UNP274.14+0.04 (+0.01%) ▲|UPS93.93-0.32 (-0.34%) ▼|USB58.15-0.63 (-1.07%) ▼|V366.03-1.71 (-0.47%) ▼|VZ45.99-0.69 (-1.48%) ▼|WFC80.50-0.31 (-0.38%) ▼|WMT106.80-1.93 (-1.78%) ▼|XOM161.40-1.12 (-0.69%) ▼|AAPL329.70-8.71 (-2.57%) ▼|ABBV263.82-2.46 (-0.92%) ▼|ABT100.84-0.15 (-0.14%) ▼|ACN177.06+2.59 (+1.48%) ▲|ADBE232.74+1.73 (+0.75%) ▲|AMAT511.28+24.52 (+5.04%) ▲|AMD607.39-0.49 (-0.08%) ▼|AMGN423.06+4.93 (+1.18%) ▲|AMT167.39-0.62 (-0.37%) ▼|AMZN246.80+0.65 (+0.26%) ▲|AVGO355.02+5.45 (+1.56%) ▲|AXP305.34-0.99 (-0.32%) ▼|BA187.60+3.21 (+1.74%) ▲|BAC55.03-0.45 (-0.80%) ▼|BKNG161.93-1.94 (-1.18%) ▼|BLK1,069.30-1.95 (-0.18%) ▼|BMY62.53-1.35 (-2.11%) ▼|BNY146.99-1.45 (-0.98%) ▼|BRK-B502.71-0.38 (-0.08%) ▼|C130.96-0.35 (-0.27%) ▼|CAT827.55+7.60 (+0.93%) ▲|CL86.39-0.14 (-0.16%) ▼|CMCSA21.57-0.22 (-1.02%) ▼|COF196.88+0.42 (+0.21%) ▲|COP125.45-0.59 (-0.47%) ▼|COST924.62+1.70 (+0.18%) ▲|CRM225.73-1.54 (-0.68%) ▼|CSCO106.94+0.20 (+0.18%) ▲|CVS86.66-1.19 (-1.35%) ▼|CVX204.13-2.24 (-1.09%) ▼|DE680.05-9.54 (-1.38%) ▼|DHR226.01-1.32 (-0.58%) ▼|DIS105.14-0.46 (-0.43%) ▼|DUK114.32+0.91 (+0.80%) ▲|EMR157.40-1.99 (-1.25%) ▼|FDX287.41-2.25 (-0.78%) ▼|GD332.33-1.83 (-0.55%) ▼|GE318.84+0.60 (+0.19%) ▲|GEV964.19+14.42 (+1.52%) ▲|GILD151.38-0.84 (-0.55%) ▼|GM80.23-0.42 (-0.51%) ▼|GOOG338.26-0.90 (-0.27%) ▼|GOOGL341.74-1.01 (-0.29%) ▼|GS915.75-0.53 (-0.06%) ▼|HD288.33-1.56 (-0.54%) ▼|HON210.55-0.97 (-0.46%) ▼|IBM220.25-0.42 (-0.19%) ▼|INTC115.89-0.14 (-0.12%) ▼|INTU266.82-2.58 (-0.96%) ▼|ISRG412.62-2.17 (-0.52%) ▼|JNJ267.57-4.38 (-1.61%) ▼|JPM335.13-1.46 (-0.43%) ▼|KO86.92-0.26 (-0.30%) ▼|LIN474.45+2.41 (+0.51%) ▲|LLY1,183.98-0.80 (-0.07%) ▼|LMT512.72-5.39 (-1.04%) ▼|LOW187.17-0.50 (-0.26%) ▼|LRCX323.55+9.08 (+2.89%) ▲|MA564.61-3.65 (-0.64%) ▼|MCD233.79+0.19 (+0.08%) ▲|MDLZ59.41-0.77 (-1.28%) ▼|MDT87.21-2.30 (-2.56%) ▼|META736.84+21.22 (+2.97%) ▲|MMM168.68-0.80 (-0.47%) ▼|MO68.62-0.51 (-0.74%) ▼|MRK149.07+0.38 (+0.26%) ▲|MS192.82-0.82 (-0.42%) ▼|MSFT509.81+0.59 (+0.12%) ▲|MU1,068.20+14.22 (+1.35%) ▲|NEE76.00+0.51 (+0.67%) ▲|NFLX70.31+1.08 (+1.56%) ▲|NKE35.88-0.51 (-1.40%) ▼|NOW130.00-1.45 (-1.10%) ▼|NVDA227.97-0.89 (-0.39%) ▼|ORCL138.33+5.73 (+4.32%) ▲|PEP128.77+0.27 (+0.21%) ▲|PFE28.62-0.10 (-0.33%) ▼|PG148.27-0.76 (-0.51%) ▼|PLTR186.79-0.70 (-0.37%) ▼|PM193.43-0.33 (-0.17%) ▼|QCOM183.95-3.53 (-1.88%) ▼|RTX187.19-0.47 (-0.25%) ▼|SBUX95.43+0.16 (+0.17%) ▲|SCHW99.10+0.80 (+0.81%) ▲|SO83.47+1.12 (+1.35%) ▲|SPG204.31-0.22 (-0.11%) ▼|T24.49-0.41 (-1.65%) ▼|TMO680.15+1.55 (+0.23%) ▲|TMUS163.19-3.27 (-1.96%) ▼|TSLA352.76-4.69 (-1.31%) ▼|TXN281.69+3.38 (+1.21%) ▲|UBER69.39+1.23 (+1.80%) ▲|UNH374.95-2.88 (-0.76%) ▼|UNP274.14+0.04 (+0.01%) ▲|UPS93.93-0.32 (-0.34%) ▼|USB58.15-0.63 (-1.07%) ▼|V366.03-1.71 (-0.47%) ▼|VZ45.99-0.69 (-1.48%) ▼|WFC80.50-0.31 (-0.38%) ▼|WMT106.80-1.93 (-1.78%) ▼|XOM161.40-1.12 (-0.69%) ▼|
21.5 C
New York
Tuesday, September 29, 2026

Tag: time

MGI Tech Receives CE Mark for DNBSEQ-T1+ Sequencer

SHENZHEN, China, June 20, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation...

NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update

TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotech company developing exosome-based therapies for central nervous system injuries, announced today that it has been accepted into the HealthTech Hub (“HTH”) Accelerator Program. Based in Boston, Massachusetts, home to more than 1,000 biotech companies1, HTH is operated by the Advanced Regenerative Manufacturing Institute (“ARMI”) and its BioFabUSA initiative.

TECNO POVA 7 Series Launches: Boasting Refreshing Trendy Design, AI-Driven Gaming Power and Numerous Surprising Features

HONG KONG, June 20, 2025 /PRNewswire/ -- TECNO, an AI-driven innovative technology brand, unveils the POVA 7 Series today with the most significant performance...

Sigma Enterprises Company and IRISS Join Forces to Advance Industrial Reliability and Safety Across the UAE

ABU DHABI, UAE, June 20, 2025 /PRNewswire/ -- IRISS, a global leader in electrical maintenance safety devices and condition-based monitoring (CBM) technologies, has entered a...

New Global Aesthetics Report: A Shift Towards Facial Surgery Globally as Eyelid Ranks Top Procedure

Aesthetic Procedures Close to 38 Million in 2024. MOUNT ROYAL, N.J., June 20, 2025 /CNW/ -- The International Society of Aesthetic Plastic Surgery (ISAPS) released the...

EMA Confluence Validates Trend Continuation Setup

OverviewThe Multiple EMA Trend Confirmation Trading System is rooted in technical analysis, leveraging Exponential Moving Averages (EMAs) and multi-timeframe charts to identify trend direction...

RSI Momentum Breakout Strategy: Overbought/Oversold Zone Analysis

OverviewThe RSI Overbought/Oversold Zone Momentum Breakout Strategy is designed to harness market momentum shifts using the Relative Strength Index (RSI). This strategy identifies breakout...

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP

Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

Analyzing Annuity Costs: A Detailed Breakdown for Strategic Financial Planning

Annuities, while potentially beneficial under certain circumstances, require careful scrutiny due to their associated costs. The primary concern is the substantial fees that can...

Chinese Firms Eye Brazil—Because Who Needs Stability Anyway?

Amid the relentless cacophony of trade wars and collapsing markets, Chinese consumer brands, with a touch of desperation and a sprinkle of audacity, have...

Cochlear celebrates 30 Years in China and the launch of the world’s first and only smart hearing implant system

The new Cochlear™ Nucleus® Nexa™ System is the first and only hearing implant featuring internal memory and upgradeable firmware.1+This year marks the 30-year anniversary since...

Key Investment Principles from The Intelligent Investor: Evidence-Based Analysis

In a May 2025 appearance on Morningstar's The Long View podcast, Wall Street Journal columnist Jason Zweig provided crucial insights for investors facing significant...

VSGG Debuts Vietnam’s First Esports Intelligence Platform to Lead Data-Driven Gaming Era

HO CHI MINH CITY, Vietnam, June 20, 2025 /PRNewswire/ -- As 2025 becomes a milestone year for Vietnamese esports, VSGG, the first locally developed esports...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTime